CS268645B1 - Derivatives of thioallophanic acid - Google Patents
Derivatives of thioallophanic acid Download PDFInfo
- Publication number
- CS268645B1 CS268645B1 CS887193A CS719388A CS268645B1 CS 268645 B1 CS268645 B1 CS 268645B1 CS 887193 A CS887193 A CS 887193A CS 719388 A CS719388 A CS 719388A CS 268645 B1 CS268645 B1 CS 268645B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- derivatives
- mol
- compounds
- acid
- thioallophanic
- Prior art date
Links
- 239000002253 acid Substances 0.000 title claims description 3
- 125000000879 imine group Chemical group 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 125000004434 sulfur atom Chemical group 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 5
- 230000000507 anthelmentic effect Effects 0.000 description 4
- 108010034145 Helminth Proteins Proteins 0.000 description 3
- 241001464384 Hymenolepis nana Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 244000000013 helminth Species 0.000 description 3
- 230000009545 invasion Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 3
- 229940116357 potassium thiocyanate Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 description 2
- 241000242722 Cestoda Species 0.000 description 1
- 241000404582 Hymenolepis <angiosperm> Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- VPLYGTXBPICDGH-UHFFFAOYSA-N methyl n-(4-methylpiperazine-1-carbothioyl)carbamate Chemical compound COC(=O)NC(=S)N1CCN(C)CC1 VPLYGTXBPICDGH-UHFFFAOYSA-N 0.000 description 1
- LBFAAYMITJMZOC-UHFFFAOYSA-N methyl n-(sulfanylidenemethylidene)carbamate Chemical compound COC(=O)N=C=S LBFAAYMITJMZOC-UHFFFAOYSA-N 0.000 description 1
- HVURUFDELNDMNP-UHFFFAOYSA-N methyl n-(thiomorpholine-4-carbothioyl)carbamate Chemical compound COC(=O)NC(=S)N1CCSCC1 HVURUFDELNDMNP-UHFFFAOYSA-N 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Vynález se týká methylesterů v poloze 4 disubstituovaných thioa1lofanových kyselin obecného vzorceThe present invention relates to methyl esters at the 4-position of disubstituted thioalofanoic acids of the general formula
X N-CS-NHC00CH3 (I), kde X je atom síry nebo iminová skupina/ substituovaná methylem.X N-CS-NHCOCH 3 (I) wherein X is a sulfur atom or an imine group / substituted with methyl.
Tyto nové dosud nepopsané látky vykazují použitelnou anthelmintickou účinnost, zejména proti modelovému helmintu Hymenolepis nana.These novel substances, which have not yet been described, exhibit useful anthelmintic activity, in particular against the model helminth of Hymenolepis nana.
Sloučeniny obecného vzorce I podle vynálezu lze připravit reakcí thiomorfo1 inu nebo N-methylpiperazinu s methoxykarbony 1isothickyanátem v prostředí acetonu při teplotě 20 až 40 °C.The compounds of the formula I according to the invention can be prepared by reacting thiomorpholine or N-methylpiperazine with methoxycarbonyl isothicyanate in acetone at 20 to 40 ° C.
Methoxykarbony1isothiokyanát byl získán reakcí thiokyanatanu draselného s methylesterem ch loromravenčí kyseliny v prostředí vroucího acetonu.Methoxycarbonyl isothiocyanate was obtained by reacting potassium thiocyanate with chloroformic acid methyl ester in boiling acetone.
Hodnocení anthelmintické účinnosti proti modelovému helmintu Hymenolepis nana:Evaluation of anthelmintic activity against model helminth Hymenolepis nana:
Testy byly provedeny na myších samcích kmene H s hmotností 10 až 13 g ve skupinách po 6 kusech. Ově ze tří kontrolních skupin byly invadované, neléčené, třetí invadovaná, léčena standardním přípravkem - piperazinovou solí niclosamidu - vůči němuž byla účinnost látek porovnávána. Invase byla prováděna sondou perorálně vždy 500 zralými vajíčky tasennice Hymenolepis nana v objemu 0,25 ml/myš. Sloučeniny obecného vzorce I byly aplikovány 13. a 14. den po invasi perorálně sondou v dávce 150 mg.kg1 živé hmotnosti, jako homogenát v Dorfmannově činidle. Myši byly usmrceny 3. den po aplikaci a po zjištění celkového počtu tasemnic se skolexy při úplné, helmintologické pitvě tenkého střeva myší byla výpočtem metodou nepřímé aktivity dle Stewarda stanovena anthelmintická účinnost. Standard byl aplikován rovněž 13. a 14. den po invasi v dávce 150 mg.kg1 Živé hmotnosti.The tests were performed on male H strain mice weighing 10-13 g in groups of 6 each. Of the three control groups, the controls were invaded, untreated, the third invaded, treated with a standard formulation - niclosamide piperazine salt - against which the efficacy of the compounds was compared. Invasion was performed by probing orally with 500 mature Hymenolepis nana tapeworm eggs in a volume of 0.25 ml / mouse. Compounds of formula I were administered on the 13th and 14th day after the invasion by oral gavage at a dose of 150 mg.kg 1 liveweight as homogenates Dorfmannově agent. Mice were sacrificed on day 3 after administration and, after total colonic tapeworm counts at complete, helminthological dissection of the small intestine of mice, anthelmintic efficacy was determined by Steward's indirect activity calculation. The standard was also applied to the 13th and 14th day after the invasion in a dose of 150 mg.kg 1 bodyweight.
Antihelmintická účinnost sloučenin obecného vzorce nana vyjádřená v procentech metodou nepříméThe anthelmintic activity of the compounds of formula nana, expressed as a percentage by the indirect method
Hymenolepis dující: иHymenolepis: no
I proti modelovému helmintu aktivity dle stewarda je náslelátky dle látky dle př íк ladu př íkladu provedení 1 provedení 2Even against the model helminth activity according to steward is the follower according to the substance according to example example 1
75.2 %75.2%
71.2 % v ní71.2% in it
Způsob uspokojivých výtěžcích. Bližší • Uvedené příklady vynález pouze ilustrují, přípravy látek podle a poskytuje žádané produkty vynálezu je jednoduchý podrobnosti vyplývají z následujících příkladů provedenikoliv omezuj í·Method of satisfactory yields. DETAILED DESCRIPTION OF THE INVENTION The following examples are merely illustrative of the preparation of the compounds of the present invention and provide the desired products of the invention.
Příklad iExample i
4-(Me thoxykarbonylamino th ioka rbony1)th iomor fo1 i n4- (Methoxycarbonylamino thiocarbonyl) thiomorpholine
К roztoku 5,83 g (0,06 mol) thiokyanatanu draselného ve 125 ml acetonu přidáno 5,67 g (4/62 «1’ 0/06 mol) methylesteru chloromravenČ1 kyseliny a směs vařena 30 min· pod zpětným chladičem· po chlazení na teplotu 20 °C byl odsát vyloučený chlorid draselný а к filtrátu bylo za míchání přikapáno 5/16 g (5,02 ml* 0,05 mol) thiomorfolinu. Kapalná reakční směs míchána 5 h, potom oddestilována ve vakuu aceton, kapalný zbytek zředěn 60 ml methanolu a ponechán 24 h v chladničce při teplotě 5 °C. Vyloučená látka odsáta a překrystalizována z methanolu· Získáno 6,05 g (55,0 %) látky tající při 124 až 125 °C o složení C7H 12 N2°2S2*To a solution of potassium thiocyanate (5.83 g, 0.06 mol) in acetone (125 ml), 5.67 g (4/62 1 0.06 mol) of methyl chloroformate were added and the mixture was refluxed for 30 min. · After cooling. The precipitated potassium chloride was aspirated to 20 ° C and 5/16 g (5.02 mL * 0.05 mol) of thiomorpholine was added dropwise to the filtrate with stirring. The liquid reaction mixture was stirred for 5 h, then distilled under vacuum in acetone, the liquid residue diluted with 60 mL of methanol and left in a refrigerator at 5 ° C for 24 h. The precipitate was filtered off with suction and recrystallised from methanol · Get 6.05 g (55.0%) of material melting at 124-125 ° C of the composition C 7 H 12 N 2 S 2 ° 2 *
Příklad 2Example 2
4—(Methoxykarbonylaminoth iokarbonyl)-l-methylp iperaz in4- (Methoxycarbonylaminothiocarbonyl) -1-methylpiperazine
Způsobem popsaným v příkladu 1 byla z 5,83 g (0,06 mol) thiokyanataůu draselnéhoThe method described in Example 1 was potassium thiocyanate (5.83 g, 0.06 mol)
5/67 g (0/006 mol) methylesteru chloromravenčí kyseliny a 5/01 g (0,05 wol) 1-methylpiperazinu připravena surová látka/ která byla překrlstalizována z methanolu· Získáno5/67 g (0/006 mol) of methyl chloroformate and 5/01 g (0.05 wol) of 1-methylpiperazine prepared as a crude material, which was recrystallized from methanol · Obtained
5,27 g (48,6 %) látky tající při 158 až 159 °C o aložení C8H15N302S.5.27 g (48.6%) of a substance melting at 158-159 ° C, depositing C 8 H 15 N 3 0 2 S.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS887193A CS268645B1 (en) | 1988-11-01 | 1988-11-01 | Derivatives of thioallophanic acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS887193A CS268645B1 (en) | 1988-11-01 | 1988-11-01 | Derivatives of thioallophanic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CS719388A1 CS719388A1 (en) | 1989-08-14 |
| CS268645B1 true CS268645B1 (en) | 1990-03-14 |
Family
ID=5420620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS887193A CS268645B1 (en) | 1988-11-01 | 1988-11-01 | Derivatives of thioallophanic acid |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS268645B1 (en) |
-
1988
- 1988-11-01 CS CS887193A patent/CS268645B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CS719388A1 (en) | 1989-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60225316T2 (en) | CYANO ALKYLAMINO DERIVATIVES AS PROTEASE INHIBITORS | |
| DE69828276T2 (en) | New cyclic diamine compounds and remedies containing them | |
| US4512998A (en) | Anthelmintic benzimidazole carbamates | |
| DE19912638A1 (en) | Naphthylcarboxamide substituted sulfonamides | |
| DE19920790A1 (en) | Bis-sulfonamides with anti-HCMV activity | |
| DE4304650A1 (en) | Condensed 5-membered heterocycles, processes for their preparation and pharmaceutical compositions containing them | |
| EP0612738A1 (en) | Diphenylpiperazine derivative and drug for circulatory organ containing the same | |
| EP0228959B1 (en) | Aminostyryl compound, leukotriene antagonistic composition containing the same as effective ingredients and method of antagonizing srs by employing the same | |
| US6969711B2 (en) | Cyclic diamine compounds and medicine containing the same | |
| EP0041047A2 (en) | Dioxide compounds, process for their preparation and their use | |
| EP0019440B1 (en) | Benzimidazolone derivatives, process for their preparation and pharmaceutical compositions containing them | |
| AU2006277794A1 (en) | Dihydroxyanthraquinones and their use | |
| HU200451B (en) | Process for production of derivatives of 1,2-ditiol-3-tion and medical compositions containing them as active substance | |
| US5344842A (en) | Thiosemicarbazone derivatives | |
| US3504026A (en) | Benzenesulfonyl-ureas | |
| DE3135250A1 (en) | TRICYCLIC THIAZOLYLOXAMATES, METHOD FOR THE PRODUCTION THEREOF AND THERAPEUTIC AGENTS CONTAINING THEM | |
| CS268645B1 (en) | Derivatives of thioallophanic acid | |
| EP0211157B1 (en) | Isoxazole derivatives, process for their preparation and phamaceutical compositions containing them | |
| GB2148296A (en) | 1,2-dithiolan derivatives, process for their production pharmaceutical compositions containing them and their use | |
| US3894033A (en) | 5-Aryltetrazoles | |
| EP0192191B1 (en) | Homocysteine thiolactone derivatives, process for the preparation thereof and pharmaceutical compositions therefrom | |
| US3853876A (en) | Ortho-mercaptoaroylamides and salts thereof abstract of the disclosure | |
| US3475450A (en) | Arylsulfonylureas and arylsulfonylthioureas | |
| US5246927A (en) | Benzazole derivatives, processes for their preparation containing such compounds and the use thereof | |
| SU1553012A3 (en) | Method of producing derivatives of 9-(2-propoxymethyl)guanine |